Institutul National Pentru Sanatatea Mamei Si Copilului Alessandrescu-Rusescu
- Address
- Bulevardul Lacul Tei Nr. 120, 020395 Bucharest, Romania
Pediatric Asthma and Severe Uncontrolled Asthma
Research at Institutul National Pentru Sanatatea Mamei Si Copilului Alessandrescu-Rusescu focuses on respiratory tract diseases, specifically asthma and its severe, uncontrolled form in children. The trials aim to evaluate new therapeutic options that can better control symptoms and reduce exacerbations.
- Effectiveness of biologic agents in young patients
- Comparative outcomes of triple‑therapy inhalers versus standard care
- Safety and tolerability of emerging treatments in the pediatric population
By advancing knowledge in these areas, the site seeks to improve daily breathing health for children living with severe asthma.
Respiratory Therapeutics Innovation
The center’s work in respiratory tract diseases explores cutting‑edge interventions aimed at lowering asthma attacks and enhancing lung function. Trials compare novel agents such as tezepelumab and the triple combination inhaler QVM149 against established therapies to demonstrate superior efficacy.
- Reduction of severe asthma exacerbations
- Improvement of forced expiratory volume (FEV1) outcomes
- Development of personalized treatment pathways for adolescents
Located on Bulevardul Lacul Tei in Bucharest, the institute contributes to European efforts to bring more effective respiratory treatments to patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1AstraZeneca AB1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institutul National Pentru Sanatatea Mamei Si Copilului Alessandrescu-Rusescu
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized Double-Blind Placebo-Controlled Study of Tezepelumab in Pediatric Patients Aged 5 to <12 Years with Severe Uncontrolled Asthma | AstraZeneca AB | Phase III | Recruiting | Dec 2023 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluticasone Propionate | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.